• Bio-IT World 2014: Notes from the Expo Floor

    Bio-IT World | The Bio-IT World Conference & Expo started yesterday evening with a fantastic opening keynote address from John Quackenbush, CEO of GenoSpace and professor at Dana-Farber Cancer Institute and a welcoming reception on a packed Expo Hall floor. Over 2,800 life sciences, pharmaceutical, clinical, healthcare, and IT professionals will join us this week for three days of programming across 13 tracks. Here’s a brief summary of some of the news and announcements made thus far. 

    Apr 30, 2014
  • April News and Product Briefs

    Bio-IT World | News and product releases from around the industry, including new prognostics for cancer care, and a bioinformatics suite for NGS data in cancer research.

    Apr 25, 2014
  • Persephone, the Real-Time Genome Browser

    Bio-IT World | Though Ceres never expected to become a software provider, the plant engineering company has found itself with a platform for viewing and exploring genetic data that it believes will vastly outperform the industry standard.

    Apr 25, 2014
  • Working Group Recommendations for Investigating Causality for Sequence Variants

    Bio-IT World | An excellent Nature Perspectives piece, published today, takes on the issues surrounding causality. The paper represents the conclusions of a working group of experts in genomic research, analysis and clinical diagnostic sequencing convened by the US National Human Genome Research Institute.

    Apr 23, 2014
  • BaseHealth Seeks New Model for Offering Patients Genetic Health Information

    Bio-IT World | This morning, Los Altos-based startup BaseHealth emerged from stealth mode to announce the launch of Genophen, a preventive medicine platform that unites clinical and genetic data to help patients track and manage their risk of developing common chronic diseases.

    Apr 22, 2014
  • More Big Pharma Shakeup: Novartis, GSK Trade Assets

    REuters | Novartis and GlaxoSmithKline announced this morning that they two big pharma are trading over $20 billion worth of assets in an attempt to strengthen their best businesses

    Apr 22, 2014
  • Pfizer Rebuffed by AstraZeneca, Regroups

    Bloomberg | Talks between Pfizer and AstraZeneca fizzled, but the possibility foretells future big deals, analysts say.

    Apr 22, 2014
  • To Speed Sequencing, Edico Genome Proposes NGS Processor

    Bio-IT World | Of sequencing bottlenecks, the most lamented is the analysis pipeline. Edico Genome is developing the DRAGEN Bio-IT Processor, the world’s first Next Generation Sequencing (NGS) bioinformatics ASIC to speed and smooth that process.

    Apr 21, 2014
  • Remarkable Twin Study Widens View of Down's Syndrome

    Bio-IT World News Brief | A large coalition of European and American researchers this week published a new gene expression study of trisomy 21, better known as Down's syndrome, using a novel cellular model of the disorder.

    Apr 18, 2014